HAP Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,400
Closed -$18K 2004
2022
Q3
$18K Sell
12,400
-4,500
-27% -$7.01K ﹤0.01% 1205
2022
Q2
$21K Buy
+16,900
New +$24.9K ﹤0.01% 1322
2021
Q3
Sell
-17,800
Closed -$8K 2886
2021
Q2
$8K Sell
17,800
-6,400
-26% -$37.5K ﹤0.01% 2060
2021
Q1
$9K Sell
24,200
-28,800
-54% -$193K ﹤0.01% 1671
2020
Q4
$45K Sell
53,000
-21,800
-29% -$110K ﹤0.01% 1444
2020
Q3
$386K Sell
74,800
-100,900
-57% -$604K 0.02% 469
2020
Q2
$505K Sell
175,700
-449,500
-72% -$3.4M 0.03% 432
2020
Q1
$1.11M Sell
625,200
-707,200
-53% -$5.67M 0.07% 204
2019
Q4
$2.7M Buy
1,332,400
+989,600
+289% +$7.2M 0.15% 100
2019
Q3
$3.13M Buy
342,800
+301,300
+726% +$2.44M 0.26% 72
2019
Q2
$181K Buy
41,500
+6,500
+19% +$117K 0.01% 513
2019
Q1
$10K Buy
35,000
+10,600
+43% +$266K ﹤0.01% 935
2018
Q4
$47K Buy
+24,400
New +$499K ﹤0.01% 760
2017
Q1
Sell
-10,600
Closed -$9K 1323
2016
Q4
$9K Sell
10,600
-12,100
-53% -$426K ﹤0.01% 857
2016
Q3
$49K Buy
+22,700
New +$487K ﹤0.01% 708
2013
Q4
Sell
-40,000
Closed -$269K 1388
2013
Q3
$269K Buy
+40,000
New +$2.84M 0.01% 656

Other funds holding CLVS

HAP Trading's CLVS Position: Q4 2021 in Review

HAP Trading sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 54,014 shares — an estimated $200K sold.

HAP Trading first reported a position in CLVS in Q1 2016 and held it in 7 quarters. The position peaked at $3.73M in Q2 2019. 154 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • HAP Trading reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 54,014 Clovis Oncology, Inc. shares in Q4 2021, an estimated $200K.
  • HAP Trading first reported a position in Clovis Oncology, Inc. in Q1 2016 and held it in 7 quarters.
  • HAP Trading's Clovis Oncology, Inc. position peaked at $3.73M in Q2 2019.
  • 154 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.